Table 1.
Study | Population | Main results | LOD score§ |
---|---|---|---|
Framingham Heart Study
(Joost et al 2002) |
Healthy Subjects:
1578 members of 330 families |
Chromosome 6: FEV1 | 2.4 |
Chromosome 21: FVC | 2.6 | ||
National Heart, Lung and Blood Institute Family Heart Study
(Wilk et al 2003) |
Healthy Subjects:
2178 members of 391 families |
Chromosome 4: FEV1/FVC | 3.5 |
Chromosome 18: FEV1 | 2.5 | ||
Chromosome 18: FVC | 2.9 | ||
Boston Early-onset Study
(Silverman et al 2002) |
Patients with COPD + Pedigrees:
585 members of 72 families |
Chromosome 2q: FEV1/FVC | 4.13 |
Chromosome 12p: FEV1 | 3.26* | ||
Chromosome 19q: Chronic bronchitis | 3.30* | ||
Chromosome 12p: Airway Obstruction | 3.14* | ||
Netherland Asthma Study
(Postma et al 2005) |
Patients with Asthma + Pedigrees:
200 families |
Chromosome 2q: Pre- and postbronchodilator FEV1%VC | 4.9/6.03** |
LOD > 3 denotes significant evidence for linkage; LOD < 3 denotes suggestive evidence;
only smoker;
pre- and postbronchodilator FEV1%VC was obtained for chromosome 2q (2q32, LOD 4,9/6.03).